Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ERYTECH PHARMA S.A.
10/26JMP Securities Downgrades ERYTECH Pharma to Market Perform From Market Outperform
MT
10/26Cowen Downgrades ERYTECH Pharma to Market Perform From Outperform
MT
10/25ERYTECH PHARMA S A : ▪The prespecified subgroup of patients treated with eryaspase a..
PU
10/25Health Care Stocks Mixed Premarket Monday
MT
10/25ERYTECH PHARMA S A : Health Care
MT
10/25ERYTECH PHARMA S A : Shares Drop 43% As Pancreatic Cancer Trial Fails Primary Endpoint
MT
10/25ERYTECH PHARMA S A : Pancreatic Cancer Drug Fails to Meet Primary Endpoint of Late-Stage S..
MT
10/25ERYTECH PHARMA S A : Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patien..
AQ
10/25ERYTECH Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patients with Se..
CI
10/05ERYTECH PHARMA S A : Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator S..
PU
10/05ERYTECH PHARMA S A : Announces maximum tolerated dose declared in a phase 1 investigator s..
AQ
10/04ERYTECH PHARMA S A : Says Early Trial of Lead Therapy Showed 'Encouraging Clinical Activit..
MT
10/04ERYTECH PHARMA S A : Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator S..
AQ
10/04ERYTECH Pharma S.A. Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator..
CI
09/28ERYTECH PHARMA S A : to Participate in the HealthTech Innovation Days (HTID) by France Bio..
AQ
More most relevant news
All news about ERYTECH PHARMA S.A.
12:09pEuropean ADRs 0.3% Lower Wednesday as Equinor, Rio Tinto Retreat
MT
10/26JMP Securities Downgrades ERYTECH Pharma to Market Perform From Market Outperform
MT
10/26Cowen Downgrades ERYTECH Pharma to Market Perform From Outperform
MT
10/25NASDAQ 100 : Top Midday Decliners
MT
10/25European ADRs Move Lower in Monday Trading
MT
10/25ERYTECH PHARMA S A : ▪The prespecified subgroup of patients treated with eryaspase a..
PU
10/25GLOBAL MARKETS LIVE : HSBC, PayPal, Tesla, Daimler, Intel...
10/25Wall Street Sees Cautiously Higher Open Ahead of Busy Week for Tech Earnings; FB Earnin..
MT
10/25Health Care Stocks Mixed Premarket Monday
MT
10/25ERYTECH PHARMA S A : Health Care
MT
More news
News in other languages on ERYTECH PHARMA S.A.
12:09pLes ADR européens en baisse de 0,3 % mercredi, en raison du recul d'Equinor et de Rio T..
10/26Erytech Pharma, plus forte baisse du SRD à la clôture du mardi 26 octobre 2021
10/25Les ADR européens en baisse lundi
10/25ERYTECH PHARMA S A : plus forte baisse du SRD à la clôture du lundi 25 octobre 2021
10/25Les actions du secteur de la santé sont mitigées lundi avant le marché
10/25ERYTECH PHARMA S A : plus forte baisse du SRD à la mi-séance du lundi 25 octobre 2021
10/25ERYTECH : le titre décroche après l'échec d'un essai clinique
10/25Les actions d'Erytech Pharma chutent de 43% après l'échec du critère principal d'un ess..
10/25ERYTECH PHARMA S A : chute après l'échec de son principal programme
10/25Le médicament d'Erytech Pharma contre le cancer du pancréas ne répond pas au critère pr..
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
10/26JMP Securities Downgrades ERYTECH Pharma to Market Perform From Market Outperform
MT
10/26Cowen Downgrades ERYTECH Pharma to Market Perform From Outperform
MT
More recommendations
Press releases
10/25ERYTECH PHARMA S A : ▪The prespecified subgroup of patients treated with eryaspase a..
PU
10/25ERYTECH PHARMA S A : Announces Results from TRYbeCA-1 Phase 3 Trial of Eryaspase in Patien..
AQ
10/05ERYTECH PHARMA S A : Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator S..
PU
10/05ERYTECH PHARMA S A : Announces maximum tolerated dose declared in a phase 1 investigator s..
AQ
10/04ERYTECH PHARMA S A : Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator S..
AQ
More press releases
Upcoming event on ERYTECH PHARMA S.A.